Last Updated:
Name Designation Appointment Date Status
Bitra Vijay Deep

Appointed as Director since October 2018

Director 22-Oct-2018 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Gowtham Varma Bhupathiraju

Appointed as Director since January 2021

Director 06-Jan-2021 Current

People Timeline

Explore the timeline of key personnel in Genoven Pharma Remedials Private Limited's leadership journey.

Loading...
Contact Details
  • Address 102 Leeladhar Enclave, Plot No 43 8-3-167/K/43 Kalyan Nagar Phase Iii, Hyderabad Telangana, 500018, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 500018
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Genoven Pharma Remedials Private Limited?
You can contact Genoven Pharma Remedials Private Limited through their registered address at 102 Leeladhar Enclave, Plot No 43 8-3-167/K/43 Kalyan Nagar Phase Iii, Hyderabad Telangana, 500018, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Genoven Pharma Remedials Private Limited?
The current directors of Genoven Pharma Remedials Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • BITRA VIJAY DEEP
  • GOWTHAM VARMA BHUPATHIRAJU
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available